CUE Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Cue Biopharma Inc

Watchlist Manager

Watchlist

Price: 28 USD -8.2% Market Closed

Market Cap: $221.4m

	Cue Biopharma Inc NASDAQ:CUE	US
I	Intel Corp MIL:INTC	US
	Baloise Holding AG SIX:BALN	CH
C	Colombia Energy Resources Inc OTC:CERX	US
P	Patagonia Lithium Ltd ASX:PL3	AU
	Future Fuels Inc XTSX:FTUR	CA
	Certara Inc NASDAQ:CERT	US
	Macy's Inc NYSE:M	US
D	Digihost Technology Inc XTSX:DGHI	CA
L	Lemon Co Ltd KOSDAQ:294140	KR
	Arteria Networks Corp F:0YW	JP
N	Nice Ltd TASE:NICE	IL
T	Toray Industries Inc OTC:TRYIY	JP

Profitability Summary

Cue Biopharma Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-262%

Negative 3Y Average Operating Margin

-544%

Operating Margin is Increasing

-2 951% > -262%

Negative Net Margin

-436%

Negative 3Y Average Net Margin

-547%

Net Margin is Increasing

-2 897% > -436%

Negative Free Cash Flow Margin

-133%

Negative 3Y Average Free Cash Flow Margin

-422%

Free Cash Flow Margin is Increasing

-2 160% > -133%

Negative ROE

-1 603%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-488%

Declining ROIC

-353% > -1 030%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.